Is Stem Cell Therapy Covered by Insurance or Medicare?

For the treatments most people are researching — knee injections, back pain, chronic disease, anti-ageing — the answer is no. Neither private insurance nor Medicare covers stem cell treatment in the United States or Canada.

But the full picture has an important exception, and understanding where the line falls tells you a great deal about the treatment itself.

What is covered

Haematopoietic stem cell transplantation. Bone marrow and cord blood transplants for leukaemia, lymphoma, multiple myeloma, sickle cell disease, aplastic anaemia and certain inherited immune disorders are routinely covered. These are FDA-approved, evidence-based hospital procedures with decades of outcome data.

Some approved cell and gene therapies. CAR-T cell therapies for certain blood cancers are covered, subject to criteria.

Occasionally, AHSCT for multiple sclerosis. Coverage for autologous haematopoietic stem cell transplantation in aggressive relapsing-remitting MS is inconsistent and usually requires prior authorisation, documented failure of high-efficacy disease-modifying therapy, and treatment at an experienced transplant centre. Some plans cover it; many still classify it as investigational. It is worth appealing.

What is not covered

Everything sold by regenerative and "stem cell" clinics for:

• Knee, hip, shoulder and spine pain
• Osteoarthritis
• COPD, diabetes, autism, neuropathy
• Anti-ageing, longevity, wellness, erectile dysfunction, hair loss

Why the line falls there

Insurers cover treatments that are FDA approved for the use in question and supported by evidence of benefit. The stem cell treatments sold in clinics meet neither test. They are, in insurance language, investigational or experimental — categories that are excluded by virtually every US policy.

This is worth sitting with. Insurance companies are not squeamish about cost when a treatment works; covering an effective therapy is usually cheaper than the surgery it prevents. The refusal is an evidence judgement, made by organisations with a strong financial motive to fund anything that genuinely reduces later claims.

What might be partially covered

• The initial consultation, if billed as a standard office visit by a physician in your network
• Imaging such as MRI or X-ray, if ordered for a covered diagnostic purpose
• Treating a complication afterwards, though a plan may dispute this if it arose from an excluded procedure

Health savings accounts

HSA and FSA funds can generally be used for qualified medical expenses. Whether an unapproved stem cell treatment qualifies is not straightforward, and the risk of a disallowed distribution falls on you. Ask a tax professional before assuming, and keep the itemised receipt.

What to do instead of hoping for coverage

Check ClinicalTrials.gov first. Registered trials are frequently free to participants, are overseen by an institutional review board, and are where the credible research happens. If a clinic charges you $20,000 to join its "study," that is not a clinical trial in any meaningful sense.

Appeal if you have aggressive MS. AHSCT denials are genuinely appealable with good documentation and a supportive neurologist.

Get the denial in writing before paying cash, so you have a record of what your plan excluded.

Sources

1. US Food and Drug Administration — Approved Cellular and Gene Therapy Products.
2. Autologous haematopoietic stem cell transplantation for multiple sclerosis and NMOSD — recommendations from ECTRIMS and the EBMT. Nature Reviews Neurology, 2024.
3. Centers for Medicare & Medicaid Services — coverage determinations for stem cell transplantation.

---